Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.
Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Infect Immun. 2019 Nov 18;87(12). doi: 10.1128/IAI.00383-19. Print 2019 Dec.
Antibodies are essential for immunity against , and protective mechanisms involve blocking of ehrlichial attachment or complement and Fcγ-receptor-dependent destruction. In this study, we determined that major outer membrane protein 1 (OMP-19) hypervariable region 1 (HVR1)-specific human monoclonal antibodies (huMAbs) are protective through conventional extracellular neutralization and, more significantly, through a novel intracellular TRIM21-mediated mechanism. Addition of OMP-1-specific huMAb EHRL-15 (IgG1) prevented infection by blocking attachment/entry, a mechanism previously reported; conversely, OMP-1-specific huMAb EHRL-4 (IgG3) engaged intracellular TRIM21 and initiated an immediate innate immune response and rapid intracellular degradation of ehrlichiae. EHRL-4-TRIM21-mediated inhibition was significantly impaired in TRIM21 knockout THP-1 cells. EHRL-4 interacted with cytosolic Fc receptor TRIM21, observed by confocal microscopy and confirmed by co-immunoprecipitation. -EHRL-4-TRIM21 complexes caused significant upregulation of proinflammatory cytokine/chemokine transcripts and resulted in rapid (<30 min) nuclear accumulation of NF-κB and TRIM21 and ehrlichial destruction. We investigated the role of TRIM21 in the autophagic clearance of ehrlichiae in the presence of EHRL-4. Colocalization between EHRL-4-opsonized ehrlichiae, polyubiquitinated TRIM21, autophagy regulators (ULK1 and beclin 1) and effectors (LC3 and p62), and lysosome-associated membrane protein 2 (LAMP2) was observed. Moreover, autophagic flux defined by conversion of LC3I to LC3II and accumulation and degradation of p62 was detected, and EHRL-4-mediated degradation of was abrogated by the autophagy inhibitor 3-methyladenine. Our results demonstrate that huMAbs are capable of inhibiting infection by distinct effector mechanisms: extracellularly by neutralization and intracellularly by engaging TRIM21, which mediates a rapid innate immune response that mobilizes the core autophagy components, triggering localized selective autophagic degradation of ehrlichiae.
抗体对于抵御病原体至关重要,其保护机制涉及阻断埃立克体的附着或补体和 Fcγ 受体依赖性破坏。在这项研究中,我们确定主要外膜蛋白 1(OMP-1)超可变区 1(HVR1)特异性人源单克隆抗体(huMAb)通过传统的细胞外中和作用具有保护作用,更重要的是,通过一种新的细胞内 TRIM21 介导的机制。添加 OMP-1 特异性 huMAb EHRL-15(IgG1)通过阻止附着/进入来预防感染,这是先前报道的一种机制;相反,OMP-1 特异性 huMAb EHRL-4(IgG3)与细胞内 TRIM21 结合,引发即刻先天免疫反应,并迅速导致埃立克体的细胞内降解。在 TRIM21 敲除 THP-1 细胞中,EHRL-4-TRIM21 介导的抑制作用显著受损。EHRL-4 通过共聚焦显微镜观察和免疫共沉淀证实,与胞质 Fc 受体 TRIM21 相互作用。-EHRL-4-TRIM21 复合物导致促炎细胞因子/趋化因子转录物的显著上调,并导致 NF-κB 和 TRIM21 的迅速(<30min)核积累和埃立克体的破坏。我们研究了在 EHRL-4 存在的情况下,TRIM21 在埃立克体自噬清除中的作用。EHRL-4 调理的埃立克体、多泛素化的 TRIM21、自噬调节剂(ULK1 和 beclin 1)和效应物(LC3 和 p62)与溶酶体相关膜蛋白 2(LAMP2)之间的共定位。此外,检测到由 LC3I 向 LC3II 的转化以及 p62 的积累和降解定义的自噬流,并且自噬抑制剂 3-甲基腺嘌呤阻断了 EHRL-4 介导的降解。我们的结果表明,huMAb 能够通过不同的效应机制抑制埃立克体感染:通过中和作用进行细胞外抑制,通过结合 TRIM21 进行细胞内抑制,TRIM21 介导快速的先天免疫反应,动员核心自噬成分,引发局部选择性埃立克体的自噬降解。